Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-25 @ 3:03 AM
NCT ID:
NCT02162433
Eligibility Criteria:
Inclusion Criteria:
* Patients between 3 to 16 years of age undergoing adenotonsillectomy, with or without myringotomy or myringoplasty
* ASA 1 \& 2
Exclusion Criteria:
* Known allergy or hypersensitivity reaction to dexmedetomidine
* Organ dysfunction (renal/hepatic failure or leukemia)
* Cardiac disease (congenital or acquired)
* Airway or thoracic malformation
* Cerebral palsy
* Hypotonia
* Need for premedication
* Current/recent upper respiratory infection (within four weeks prior to the surgery)
* Asthma
* Allergy or intolerance to clonidine
* Non-English speaking parents/patients.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
16 Years
Study:
NCT02162433
Study Brief:
Protocol Section:
NCT02162433